Aarsland, Dag

Genetic evaluation of dementia with Lewy bodies implicates distinct disease subgroups

Kaivola, K., Shah, Z., Chia, R., International LBD Genomics Consortium, Black, S. E., Gan-Or, Z., Keith, J., Masellis, M., Rogaeva, E., Brice, A., et al. (2022) · Brain

Parkinson's Disease Mechanisms and TreatmentsDementia and Cognitive Impairment Research

Cited by 65

Genome-wide association identifies the first risk loci for psychosis in Alzheimer disease

DeMichele-Sweet, M. A. A., Klei, L., Creese, B., Harwood, J. C., Weamer, E. A., McClain, L., Sims, R., Hernandez, I., Moreno-Grau, S., Tárraga, L., et al. (2021) · Molecular Psychiatry

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 64

Mental health of people living with dementia in care homes during COVID-19 pandemic

Velayudhan, L., Aarsland, D., & Ballard, C. (2020) · International Psychogeriatrics

Geriatric Care and Nursing HomesCOVID-19 and Mental Health

Cited by 62

Effects of cholinergic blockade on language in healthy young women: Implications for the cholinergic hypothesis in dementia of the Alzheimer type

Aarsland, D., Larsen, J. P., Reinvang, I., & Aasland, A. M. (1994) · Brain

Neurobiology of Language and BilingualismDementia and Cognitive Impairment Research

Cited by 56

CSF amyloid 38 as a novel diagnostic marker for dementia with Lewy bodies

Mulugeta, E., Londos, E., Ballard, C., Alves, G., Zetterberg, H., Blennow, K., Skogseth, R., Minthon, L., & Aarsland, D. (2011) · Journal of Neurology, Neurosurgery & Psychiatry

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 54

A remote speech-based AI system to screen for early Alzheimer's disease via smartphones

Fristed, E., Skirrow, C., Meszaros, M., Lenain, R., Meepegama, U., Cappa, S., Aarsland, D., & Weston, J. (2022) · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 47

Urinary metabolic phenotyping for Alzheimer’s disease

Kurbatova, N., Garg, M., Whiley, L., Chekmeneva, E., Jiménez, B., Gómez-Romero, M., Pearce, J., Kimhofer, T., D’Hondt, E., Soininen, H., et al. (2020) · Scientific Reports

Metabolomics and Mass Spectrometry StudiesDementia and Cognitive Impairment Research

Cited by 44

Antidepressants and mortality risk in a dementia cohort: data from SveDem, the Swedish Dementia Registry

Enache, D., Fereshtehnejad, S. ‐., Kåreholt, I., Cermakova, P., Garcia‐Ptacek, S., Johnell, K., Religa, D., Jelic, V., Winblad, B., Ballard, C., et al. (2016) · Acta Psychiatrica Scandinavica

Dementia and Cognitive Impairment ResearchPharmaceutical Practices and Patient Outcomes

Cited by 42

Demography, diagnostics, and medication in dementia with Lewy bodies and Parkinson's disease with dementia: data from the Swedish Dementia Quality Registry (SveDem)

Fereshtehnejad, S.-M., Religa, D., Westman, Lökk, J., Eriksdotter, M., & Aarsland, D. (2013) · Neuropsychiatric Disease and Treatment

Dementia and Cognitive Impairment ResearchParkinson's Disease Mechanisms and Treatments

Cited by 42

A randomised placebo-controlled study of purified anthocyanins on cognition in individuals at increased risk for dementia

Aarsland, D., Khalifa, K., Bergland, A. K., Soennesyn, H., Oppedal, K., Holteng, L. B. A., Oesterhus, R., Nakling, A., Jarholm, J. A., de Lucia, C., et al. (2023) · The American Journal of Geriatric Psychiatry

Dementia and Cognitive Impairment ResearchPhytochemicals and Antioxidant Activities

Cited by 36

Exploring the link between GBA1 mutations and Dementia with Lewy bodies, A mini-review

Gaubert, S., Hourregue, C., Mouton-Liger, F., Millot, P., Franco, M., Amar-Bouaziz, E., Aarsland, D., Hugon, J., & Paquet, C. (2022) · Neuroscience & Biobehavioral Reviews

Lysosomal Storage Disorders ResearchParkinson's Disease Mechanisms and Treatments

Cited by 26

Clinical factors associated with progression to dementia in people with late-life depression: a cohort study of patients in secondary care

Peakman, G., Karunatilake, N., Seynaeve, M., Perera, G., Aarsland, D., Stewart, R., & Mueller, C. (2020) · BMJ Open

Dementia and Cognitive Impairment ResearchTreatment of Major Depression

Cited by 21

Risky drinking and cognitive impairment in community residents aged 50 and over

Rao, R., Creese, B., Aarsland, D., Kalafatis, C., Khan, Z., Corbett, A., & Ballard, C. (2022) · Aging & Mental Health

Dementia and Cognitive Impairment ResearchSubstance Abuse Treatment and Outcomes

Cited by 14

Consensus meta-analysis of genome-wide association studies for Alzheimer’s disease and related dementias

EADB, Bellenguez, C., Castillo Morales, A., Amin, N., van der Lee, S. J., Muntaner, M., Parveen, K., Küçükali, F., Grenier-Boley, B., Heikkinen, S., et al. (2026) · Nature Genetics

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 7

Spectrum of Lewy body dementias: relationship of Parkinson’s disease dementia to dementia with Lewy bodies

Ballard, C., Garcia-Ptacek, S., van Steenoven, I., & Aarsland, D. (2015) · Cognitive Impairment and Dementia in Parkinson's Disease

Parkinson's Disease Mechanisms and TreatmentsDementia and Cognitive Impairment Research

Cited by 5

Alzheimer’s disease genetics converges on microglial and neuronal dysregulation

Uffelmann, E., Wightman, D. P., Bahrami, S., Shadrin, A. A., Fominykh, V., Ojima, T., Jiang, C., Benner, C., Moreno, E., Campos, A. I., et al. (2026) · Nature

Alzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration Mechanisms

Cited by 0